OLAPLEX HOLDINGS, INC. recently released its 10-Q report for the quarter ended March 31, 2026. Through its subsidiaries, the company develops, manufactures, and sells haircare products in the United States and abroad, including shampoos, conditioners, oils, moisture masks, and hair serums. It also offers in-salon services aimed at repairing and shaping curls, and sells through professional distributors, retailers, e-commerce channels, and its own website.
In Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations, the company’s first-quarter results showed net sales of $99.4 million, up from $97.0 million a year earlier. Gross profit rose to $71.7 million from $67.4 million, but operating expenses increased to $76.8 million from $58.9 million, pushing the company to an operating loss of $5.1 million versus operating income of $8.5 million in the prior-year quarter. Selling, general and administrative expense climbed to $66.0 million from $48.0 million, while amortization of other intangible assets held steady at about $10.8 million.
Below operating income, interest expense fell to $7.1 million from $13.7 million, and interest income declined to $2.7 million from $6.0 million. The company reported a pretax loss of $9.7 million, compared with pretax income of $0.9 million a year earlier. After a $4.4 million income tax benefit, net loss was $5.3 million, versus net income of $0.5 million in the prior-year quarter.
The balance sheet showed cash and cash equivalents of $326.2 million at March 31, 2026, up from $318.7 million at year-end 2025. Accounts receivable increased to $37.5 million from $29.0 million, inventory rose to $66.4 million from $60.2 million, and prepaid expenses and other current assets fell sharply to $16.2 million from $62.4 million. Total current assets were $446.3 million, down from $470.3 million.
Total assets were $1.46 billion, compared with $1.50 billion at December 31, 2025. Intangible assets, net, were $834.9 million, down from $847.8 million, while goodwill remained unchanged at $168.3 million. Total liabilities decreased to $582.2 million from $618.1 million, and stockholders’ equity was $878.0 million, slightly below $879.4 million at year-end.
Long-term debt was essentially flat at $352.5 million, and the related party payable under the Tax Receivable Agreement remained $155.9 million, with another $9.2 million due within a year. Accounts payable rose to $29.2 million from $8.1 million, while accrued expenses and other current liabilities dropped to $32.8 million from $85.3 million. The company ended the quarter with 671.7 million shares outstanding, up from 669.1 million at December 31, 2025.
Cash flow was supported by a $3.5 million share-based compensation expense and a $139,000 unrealized gain on derivatives, which lifted accumulated other comprehensive loss to $198,000 from $337,000. Retained earnings declined to $531.4 million from $536.7 million, reflecting the quarter’s net loss. The market has reacted to these announcements by moving the company's shares 0.25% to a price of $2.04. For more information, read the company's full 10-Q submission here.
